These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35770352)

  • 1. Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.
    Johnsen JM; Fletcher SN; Dove A; McCracken H; Martin BK; Kircher M; Josephson NC; Shendure J; Ruuska SE; Valentino LA; Pierce GF; Watson C; Cheng D; Recht M; Konkle BA
    J Thromb Haemost; 2022 Sep; 20(9):2022-2034. PubMed ID: 35770352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.
    Rydz N; Leggo J; Tinlin S; James P; Lillicrap D
    Am J Hematol; 2013 Dec; 88(12):1030-4. PubMed ID: 23913812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.
    Johnsen JM; Fletcher SN; Huston H; Roberge S; Martin BK; Kircher M; Josephson NC; Shendure J; Ruuska S; Koerper MA; Morales J; Pierce GF; Aschman DJ; Konkle BA
    Blood Adv; 2017 May; 1(13):824-834. PubMed ID: 29296726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants.
    Villarreal-Martínez L; Ibarra-Ramirez M; Calvo-Anguiano G; Lugo-Trampe JJ; Luna-Záizar H; Martínez-de-Villarreal LE; Meléndez-Aranda L; Jaloma-Cruz AR
    Blood Cells Mol Dis; 2020 Jul; 83():102423. PubMed ID: 32224444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.
    Konkle BA; Johnsen JM; Wheeler M; Watson C; Skinner M; Pierce GF;
    Haemophilia; 2018 May; 24 Suppl 6(Suppl 6):87-94. PubMed ID: 29878652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.
    Andersson NG; Labarque V; Letelier A; Mancuso ME; Bührlen M; Fischer K; Kartal-Kaess M; Koskenvuo M; Mikkelsen T; Ljung R;
    Hum Mutat; 2020 Dec; 41(12):2058-2072. PubMed ID: 32935414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of carrier status in female members of Japanese hemophilia families.
    Shinozawa K; Amano K; Hagiwara T; Bingo M; Chikasawa Y; Inaba H; Kinai E; Fukutake K
    J Thromb Haemost; 2021 Jun; 19(6):1493-1505. PubMed ID: 33760382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent F8 and F9 gene variants result from a founder effect in two large French haemophilia cohorts.
    Lassalle F; Marmontel O; Zawadzki C; Fretigny M; Bouvagnet P; Vinciguerra C
    Haemophilia; 2018 Jul; 24(4):e213-e221. PubMed ID: 29656491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.
    Bastida JM; González-Porras JR; Jiménez C; Benito R; Ordoñez GR; Álvarez-Román MT; Fontecha ME; Janusz K; Castillo D; Fisac RM; García-Frade LJ; Aguilar C; Martínez MP; Bermejo N; Herrero S; Balanzategui A; Martin-Antorán JM; Ramos R; Cebeiro MJ; Pardal E; Aguilera C; Pérez-Gutierrez B; Prieto M; Riesco S; Mendoza MC; Benito A; Hortal Benito-Sendin A; Jiménez-Yuste V; Hernández-Rivas JM; García-Sanz R; González-Díaz M; Sarasquete ME
    Thromb Haemost; 2017 Jan; 117(1):66-74. PubMed ID: 27734074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A database.
    Ahmed AE; Pratt KP
    J Thromb Haemost; 2023 Apr; 21(4):800-813. PubMed ID: 36696179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.
    Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L
    Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience.
    González-Ramos IA; Mantilla-Capacho JM; Luna-Záizar H; Mundo-Ayala JN; Lara-Navarro IJ; Ornelas-Ricardo D; González Alcázar JÁ; Evangelista-Castro N; Jaloma-Cruz AR
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):939-954. PubMed ID: 33191626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive detection of
    Hudecova I; Jiang P; Davies J; Lo YMD; Kadir RA; Chiu RWK
    Blood; 2017 Jul; 130(3):340-347. PubMed ID: 28490568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice.
    Pezeshkpoor B; Oldenburg J; Pavlova A
    Hamostaseologie; 2022 Dec; 42(6):390-399. PubMed ID: 36549291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable and cost-effective approach for diagnosis of heterozygous F8/F9 large deletions by quantitative real-time PCR.
    Abelleyro MM; Radic CP; Tetzlaff T; Marchione V; Fundia AF; Larripa IB; Rossetti LC; De Brasi CD
    Haemophilia; 2015 May; 21(3):e247-e251. PubMed ID: 25753911
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene.
    Owaidah T; Bakr S; Al-Numair N; AbaAlkhail H; Alzahrani H; Saleh M; Khogeer H; Tarawah A; Akkad H; Al-Allaf F
    Clin Appl Thromb Hemost; 2023; 29():10760296231182410. PubMed ID: 37525882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of F8 Genotype and Genetic Impact on Inhibitor Development in Patients with Hemophilia A from Multicenter Cohort Studies (J-HIS) in Japan.
    Shinozawa K; Yada K; Kojima T; Nogami K; Taki M; Fukutake K; Yoshioka A; Shirahata A; Shima M;
    Thromb Haemost; 2021 May; 121(5):603-615. PubMed ID: 33254277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Hemophilia A (CAHEA): Towards Full Characterization of the F8 Gene Variants by Long-Read Sequencing.
    Liu Y; Li D; Yu D; Liang Q; Chen G; Li F; Gao L; Li Z; Xie T; Wu L; Mao A; Wu L; Liang D
    Thromb Haemost; 2023 Dec; 123(12):1151-1164. PubMed ID: 37285902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.